ZA985203B - Compounds useful for inhibition of farnesyl protein transferase - Google Patents

Compounds useful for inhibition of farnesyl protein transferase

Info

Publication number
ZA985203B
ZA985203B ZA985203A ZA985203A ZA985203B ZA 985203 B ZA985203 B ZA 985203B ZA 985203 A ZA985203 A ZA 985203A ZA 985203 A ZA985203 A ZA 985203A ZA 985203 B ZA985203 B ZA 985203B
Authority
ZA
South Africa
Prior art keywords
inhibition
compounds useful
protein transferase
farnesyl protein
farnesyl
Prior art date
Application number
ZA985203A
Other languages
English (en)
Inventor
Alan B Cooper
Ronald J Doll
Viyyoor M Girijavallabhan
Ashit Ganguly
John C Reader
John J Baldwin
Chia-Yu Huang
Original Assignee
Schering Corp
Pharmacopeia Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp, Pharmacopeia Inc filed Critical Schering Corp
Publication of ZA985203B publication Critical patent/ZA985203B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA985203A 1997-06-17 1998-06-15 Compounds useful for inhibition of farnesyl protein transferase ZA985203B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US87774197A 1997-06-17 1997-06-17

Publications (1)

Publication Number Publication Date
ZA985203B true ZA985203B (en) 1999-01-05

Family

ID=25370618

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA985203A ZA985203B (en) 1997-06-17 1998-06-15 Compounds useful for inhibition of farnesyl protein transferase

Country Status (18)

Country Link
EP (1) EP0989983B1 (de)
JP (1) JP2002504144A (de)
KR (1) KR100640672B1 (de)
CN (1) CN1266433A (de)
AR (1) AR012991A1 (de)
AT (1) ATE273299T1 (de)
AU (1) AU753658B2 (de)
CA (1) CA2293714C (de)
DE (1) DE69825589T2 (de)
ES (1) ES2224408T3 (de)
HU (1) HUP0003138A3 (de)
IL (2) IL133386A0 (de)
MY (1) MY143570A (de)
NZ (1) NZ501376A (de)
PE (1) PE104798A1 (de)
TW (1) TW587935B (de)
WO (1) WO1998057960A1 (de)
ZA (1) ZA985203B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU776558B2 (en) 1998-12-18 2004-09-16 Schering Corporation Tricyclic farnesyl protein transferase inhibitors
US6800636B2 (en) 1998-12-18 2004-10-05 Schering Corporation Farnesyl protein transferase inhibitors
US6362188B1 (en) 1998-12-18 2002-03-26 Schering Corporation Farnesyl protein transferase inhibitors
US6372747B1 (en) 1998-12-18 2002-04-16 Schering Corporation Farnesyl protein transferase inhibitors
BR9916328A (pt) * 1998-12-18 2001-10-02 Schering Corp Inibidores de transferase de farnesila
US6432959B1 (en) * 1998-12-23 2002-08-13 Schering Corporation Inhibitors of farnesyl-protein transferase
US7342016B2 (en) 2000-08-30 2008-03-11 Schering Corporation Farnesyl protein transferase inhibitors as antitumor agents
AU2002236813A1 (en) 2001-01-22 2002-07-30 Schering Corporation Treatment of malaria with farnesyl protein transferase inhibitors
WO2002080895A2 (en) * 2001-04-06 2002-10-17 Schering Corporation Treatment of malaria with farsenyl protein transferase inhibitors
JP4713152B2 (ja) * 2002-09-20 2011-06-29 メルク セローノ ソシエテ アノニム ピペラジン誘導体及び使用方法
JP2008523104A (ja) 2004-12-13 2008-07-03 シェーリング コーポレイション 癌を治療するための新規なファルネシルタンパク質トランスフェラーゼ阻害剤およびその使用
CA2591123A1 (en) * 2004-12-14 2006-06-22 Schering Corporation Farnesyl protein transferase inhibitors and methods for treating proliferative diseases
PT2807153T (pt) * 2012-01-25 2020-06-18 Novartis Ag Compostos heterocíclicos e métodos para seu uso
EP3541375B1 (de) * 2016-11-18 2023-08-23 Merck Sharp & Dohme LLC Faktor xiia inhibitoren

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT76066A (en) * 1993-10-15 1997-06-30 Schering Corp Tricyclic amide and urea compounds useful for inhibition of g-protein function and for treatment of proliferative diseases, pharmaceutical compositions containing them and process for producing them
IL111235A (en) * 1993-10-15 2001-03-19 Schering Plough Corp Medicinal preparations for inhibiting protein G activity and for the treatment of malignant diseases, containing tricyclic compounds, some such new compounds and a process for the preparation of some of them
IL117797A0 (en) * 1995-04-07 1996-08-04 Pharmacopeia Inc Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
US5712280A (en) * 1995-04-07 1998-01-27 Schering Corporation Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
IL117798A (en) * 1995-04-07 2001-11-25 Schering Plough Corp Tricyclic compounds useful for inhibiting the function of protein - G and for the treatment of malignant diseases, and pharmaceutical preparations containing them

Also Published As

Publication number Publication date
TW587935B (en) 2004-05-21
CN1266433A (zh) 2000-09-13
MY143570A (en) 2011-05-31
DE69825589T2 (de) 2005-09-08
HUP0003138A3 (en) 2002-11-28
AU8058098A (en) 1999-01-04
WO1998057960A1 (en) 1998-12-23
IL133386A0 (en) 2001-04-30
EP0989983A1 (de) 2000-04-05
EP0989983B1 (de) 2004-08-11
HUP0003138A2 (hu) 2001-06-28
PE104798A1 (es) 1999-11-06
ES2224408T3 (es) 2005-03-01
ATE273299T1 (de) 2004-08-15
CA2293714C (en) 2009-09-08
JP2002504144A (ja) 2002-02-05
KR20010013822A (ko) 2001-02-26
CA2293714A1 (en) 1998-12-23
DE69825589D1 (de) 2004-09-16
AU753658B2 (en) 2002-10-24
NZ501376A (en) 2002-03-28
IL133386A (en) 2006-12-10
AR012991A1 (es) 2000-11-22
KR100640672B1 (ko) 2006-11-02

Similar Documents

Publication Publication Date Title
HUP0004148A3 (en) Inhibitors of farnesyl protein transferase
IL124197A (en) Inhibitors of farnesyl protein transferase
IL126833A0 (en) Inhibitors of protein farnesyl transferase
EP0918771A4 (de) Thiadioxobenzodiazepin-inhibitoren der farnesyl-protein-transferase
EP0696593A3 (de) Inhibitoren der farnesyl protein Transferase
AU5772698A (en) Inhibitors of farnesyl protein transferase
HU9500934D0 (en) Imidazole-containing inhibitors of farnesyl protein transferase
IL123155A0 (en) 4-mercaptopyrrolidine derivatives as farnesyl transferase inhibitors
EP1027042A4 (de) Inhibitoren von farnesyl protein transferase
AP2001002058A0 (en) Farnesyl protein transferase inhibitors for treating arthropathies
GB9809869D0 (en) Inhibition of protein kinases
IL143409A0 (en) Farnesyl protein transferase inhibitors
ZA985203B (en) Compounds useful for inhibition of farnesyl protein transferase
AU5164898A (en) Thioproline-containing inhibitors of farnesyl protein transferase
ZA986623B (en) Hydantoin derivatives having an inhibitor activity for farnesyl transferase
ZA985211B (en) Benzo (5,6) cycloheptapyridine compounds useful as farnesyl protein transferase inhibitors
HUP0202152A2 (en) Tricyclyc farnesyl protein transferase inhibitors
ZA985210B (en) Compounds for the inhibition of farnesyl protein transferase
ZA985214B (en) Compounds useful for inhibition of farnesyl protein transferase
HUP0002186A3 (en) Compounds useful for inhibition of farnesyl protein transferase
IL130453A0 (en) Farnesyl transferase inhibitors
HUP9903221A3 (en) Inhibitors of protein farnesyl transferase
ZA971621B (en) Inhibitors of farnesyl protein transferase
IL149870A0 (en) Inhibitors of farnesyl protein transferase
GB9609981D0 (en) Inhibitors of farnesyl-protien transferase